Ozempic and its chemical cousins made their name as weight-loss drugs. Increasingly, that may turn out to be the least interesting thing about them. A massive VA-linked study led by researchers at the Veterans Affairs St. Louis Health Care System, analyzing records from over 100 million U.S. patients, found that GLP-1 drugs were associated with reduced risks of substance abuse disorders, suicidal ideation, schizophrenia, and other psychotic disorders — alongside lower risk of
